galantamine and Atrophy

galantamine has been researched along with Atrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, Y; Haga, Y; Hanazawa, T; Kamijo, Y; Usui, K; Yoshizawa, T1
Barkhof, F; Fox, NC; Korf, ES; Scheltens, P; van de Pol, LA; van der Flier, WM1

Trials

1 trial(s) available for galantamine and Atrophy

ArticleYear
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.
    Neurology, 2007, Oct-09, Volume: 69, Issue:15

    Topics: Age Factors; Aged; Alzheimer Disease; Apolipoprotein E4; Atrophy; Biomarkers; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Galantamine; Genetic Predisposition to Disease; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Neuropsychological Tests; Predictive Value of Tests; Prognosis

2007

Other Studies

1 other study(ies) available for galantamine and Atrophy

ArticleYear
Acute cholinergic syndrome in a patient with Alzheimer's disease taking the prescribed dose of galantamine.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2018, Volume: 18, Issue:5

    Topics: Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Galantamine; Humans; Male; Syndrome; Tomography, X-Ray Computed

2018